Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aronson

Showing results (161-170 of 634) with videos related to

Pageof 64
Sort By:
BMJ (Clinical Research Ed.)|December 18, 2021
When I use a word . . . . The Precautionary Principle: a definitionJeffrey K Aronson
Clinical Pharmacokinetics|March 1, 1980
Clinical pharmacokinetics of digoxin 1980J K Aronson
BMJ (Clinical Research Ed.)|September 19, 2025
When I use a word . . . Acronymic sleuthsJeffrey K Aronson
BMJ (Clinical Research Ed.)|November 4, 2022
When I use a word . . . . Medical words newly logged in the OED in December 2021Jeffrey K Aronson
Journal of Evaluation in Clinical Practice|April 9, 2005
Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactionsJeffrey K Aronson
Clinical Science (London, England : 1979)|March 1, 1990
Methods for expressing the characteristics of transmembrane ion transport systemsJ K Aronson
British Journal of Clinical Pharmacology|April 2, 2005
Drug development: more science, more educationJ K Aronson
BMJ (Clinical Research Ed.)|December 16, 2022
When I use a word . . . . Sydenham SocietiesJeffrey K Aronson
BMJ (Clinical Research Ed.)|May 27, 2022
When I use a word . . . . Counterfactual medical history: the death of Charles IIJeffrey K Aronson
Drug Safety|May 17, 2022
Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and LimitationsJeffrey K Aronson
Pageof 64

Showing results (161-170 of 634) with videos related to

Sort By:
Pageof 64
BMJ (Clinical Research Ed.)|December 18, 2021
When I use a word . . . . The Precautionary Principle: a definitionJeffrey K Aronson
Clinical Pharmacokinetics|March 1, 1980
Clinical pharmacokinetics of digoxin 1980J K Aronson
BMJ (Clinical Research Ed.)|September 19, 2025
When I use a word . . . Acronymic sleuthsJeffrey K Aronson
BMJ (Clinical Research Ed.)|November 4, 2022
When I use a word . . . . Medical words newly logged in the OED in December 2021Jeffrey K Aronson
Journal of Evaluation in Clinical Practice|April 9, 2005
Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactionsJeffrey K Aronson
Clinical Science (London, England : 1979)|March 1, 1990
Methods for expressing the characteristics of transmembrane ion transport systemsJ K Aronson
British Journal of Clinical Pharmacology|April 2, 2005
Drug development: more science, more educationJ K Aronson
BMJ (Clinical Research Ed.)|December 16, 2022
When I use a word . . . . Sydenham SocietiesJeffrey K Aronson
BMJ (Clinical Research Ed.)|May 27, 2022
When I use a word . . . . Counterfactual medical history: the death of Charles IIJeffrey K Aronson
Drug Safety|May 17, 2022
Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and LimitationsJeffrey K Aronson
Pageof 64